Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Construction of autologous tissue engineering blood vessel by using large-aperture parallel polycaprolactone electrospun cotton

A technology of tissue engineering and polycaprolactone, applied in the field of biomedical engineering, can solve the problems of difficult cell growth, aging, cell loss, etc., and achieve the effects of rapid growth, good mechanical properties and cell compatibility

Inactive Publication Date: 2016-11-16
SHANGHAI CHILDRENS MEDICAL CENT AFFILIATED TO SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this also brings about additional problems: (1) The process of in vitro isolation and culture expansion of seed cells is complicated, and cell contamination and aging are prone to occur; After curly transplantation, the seed cells first need to overcome the subcutaneous nutrient deficient environment, which brings about the problem of low construction success rate; (3) Cells in vitro are also prone to cell loss
[0007] The present invention hopes to solve the problem that the electrospun nanofiber membrane spun by the traditional method is fine and compact, and the cells are not easy to grow into
The large-pore size, thick fiber PCL electrospun cotton with PCL as the basic raw material and its application in autologous tissue engineering blood vessels have not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction of autologous tissue engineering blood vessel by using large-aperture parallel polycaprolactone electrospun cotton
  • Construction of autologous tissue engineering blood vessel by using large-aperture parallel polycaprolactone electrospun cotton
  • Construction of autologous tissue engineering blood vessel by using large-aperture parallel polycaprolactone electrospun cotton

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] 1. Materials and methods

[0039] 1 animal

[0040] 150g male clean SD rats are the animals involved in this experiment, all provided by Shanghai Slack Experimental Animal Co., Ltd. The animal experiment protocol and experimental operation were reviewed and approved by the experimental animal management team of Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University School of Medicine.

[0041] 2 instruments

[0042]

[0043] 3 Reagents and materials

[0044]

[0045] 4 methods

[0046] 4.1 Preparation of relevant solutions

[0047] (1) 10% and 35% polycaprolactone (PCL) electrospinning solutions

[0048] Using TFE as a solvent, weigh the PCL particles with an electronic balance, weigh them according to the solute ratio of 10% and 35% (m / v), and then transfer them into a dissolving bottle. According to the density of 1.386g / ml, measure the corresponding volume of TFE with an electronic balance and transfer it to the corresponding dissol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to large-aperture parallel polycaprolactone (PCL) electrospun cotton, and belongs to the technical field of biomedical engineering. The invention further provides a tissue blood vessel engineering scaffold and a tissue engineering blood vessel prepared by the electrospun cotton. The construction of the autologous tissue engineering blood vessel by using the large-aperture parallel PCL electrospun cotton has the advantages that (1) the large-aperture parallel PCL electrospun cotton is good in mechanical property and cell compatibility, and is conducive to rapid ingrowth of cells; (2) finally obtained tissue engineering vascular tissue cells and extracellular matrixes derive from autografts, thereby not producing immunological rejection; (3) PCL electrospun cotton fiber guide cells which are arranged in parallel and extracellular matrixes are in a directional circular arrangement, so that histological structures of natural blood vessels can be simulated.

Description

technical field [0001] The invention relates to the technical field of biomedical engineering, in particular, utilizes large-diameter parallel polycaprolactone electrospun cotton to construct autologous tissue engineering blood vessels. Background technique [0002] Several existing vascular graft substitutes still have defects such as non-growth, or allogeneic tissues are prone to immune rejection. Therefore, it is of great significance to construct new tissue-engineered blood vessels with growth properties and autologous tissues or cells. [0003] Generally, the construction of tissue engineered blood vessels first needs to solve three problems: (1) tissue scaffold, (2) source of seed cells and (3) tissue construction method. The "tissue scaffold" is the environment in which cells attach and grow. Since the artificially constructed tissue still lacks the extracellular matrix secreted by the implanted cells in the early stage of formation, it is necessary to artificially ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61F2/06A61L27/50A61L27/18
CPCA61F2/062A61F2240/001A61L27/18A61L27/50A61L27/507A61L2430/22C08L67/04
Inventor 张海波张磊冯蓓白洁唐梓清付炜
Owner SHANGHAI CHILDRENS MEDICAL CENT AFFILIATED TO SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products